Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.

Anai N KothariSandra R DiBritoJ Jack LeeAbigail S CaudleMark W ClemensVijaya N GottumukkalaMatthew H G KatzAnaeze C OffodileAbhineet Uppalnull nullGeorge J Chang

Published in: Annals of surgical oncology (2021)

A minimal wait time of 20 days after recovering from minimally symptomatic SARS-CoV-2 infection appears to be safe for cancer patients undergoing low-risk elective surgery. Patients with SARS-CoV-2 infections requiring inpatient treatment were at increased risk for adverse events after surgery. Additional wait time may be required in those with more severe infections.

Keyphrases

patients undergoing
sars cov
papillary thyroid
minimally invasive
respiratory syndrome coronavirus
coronary artery bypass
squamous cell
squamous cell carcinoma
early onset
surgical site infection
lymph node metastasis